Percheron Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Percheron Therapeutics has a total shareholder equity of A$9.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$14.5M and A$5.2M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$11.87m |
| Equity | AU$9.36m |
| Total liabilities | AU$5.17m |
| Total assets | AU$14.53m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PER's short term assets (A$14.5M) exceed its short term liabilities (A$5.2M).
Long Term Liabilities: PER's short term assets (A$14.5M) exceed its long term liabilities (A$15.2K).
Debt to Equity History and Analysis
Debt Level: PER is debt free.
Reducing Debt: PER had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PER has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PER is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.